Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 华润三九医药股份有限公司主要从事医药产品的研发、生产、销售及相关健康服务.公司以OTC(非处方药)、中药处方药、免煎中药、抗生素及普药为四大制药业务模块,辅以包装印刷、医疗服务等相关业务. 其中,999感冒灵系列2009年销售额超过10亿元(含税),位居感冒药市场第一;999皮炎平2009年销售额近5亿元(含税). 2008年,华润三九上市公司获评中国上市公司价值百强企业,并于2009年7月1日起,列入沪深300指数,深证100成份指数。
Main Business 研制、生产、销售各类中、西药
Legal Representative 邱华伟
Top Executives
董事长：邱华伟
董事：梁征,于舒天,崔兴品,白晓松,杨旭东,邱华伟,周辉
独立董事：李梦涓,贺震旦,王轶,孙健
Top 5 Shareholder
Shareholder name Nature Holding Date
华润医药控股有限公司流通A股63.00%31/03/2024
香港中央结算有限公司流通A股5.89%31/03/2024
中国工商银行股份有限公司－中欧医疗健康混合型证券投资基金流通A股3.39%31/03/2024
中国工商银行股份有限公司－东方红启恒三年持有期混合型证券投资基金流通A股0.86%31/03/2024
中国建设银行股份有限公司－工银瑞信前沿医疗股票型证券投资基金流通A股0.71%31/03/2024
Company Secretary --
Solicitors 北京海问律师事务所
Auditors 深圳中天会计师事务所
Tel No 0755-83360999-393692;0755-83360999-398612
Fax No 0755-83360999-396006
Website www.999.com.cn
Email 000999@999.com.cn
Company Address
Register: 广东省深圳市龙华区观湖街道观澜高新园区观清路1号
Office: 广东省深圳市龙华区观湖街道观澜高新园区观清路1号
Listing Date 09/03/2000
Shares Capital
Shares Capital: 988,184,000
Total A Share: 988,184,000
Listed A Share: 978,395,308
Non-tradable A Share: 9,788,692
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 2.900
DPS(RMB)* ¥ 1.500
NBV Per Share(RMB)* ¥ 19.194
Market Capitalization(RMB) 61.150B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.